OML's goal is to equip at least 25% (~6.5 million) insulin dependent diabetics in LMICs of SE Asia with affordable and effective devices within the next decade. Our aim is to make a substantial impact on diabetes management in resource-constrained settings, resulting in significant reduction in associated healthcare costs.